There has yet been no plausible theory to explain Alzheimer's disease arising among Down syndrome young adults. A microbe is proposed for that role.
Despite the absence of a curative drug, improvements in MCI may be possible though use of substances and tactics published throughout medical journals and summarized here.
There is now keen interest in deeper investigation of infectious agents as the trigger of Alzheimer's disease
Alzheimer's advocacy groups taint their credibility by not revealing conflicts when they lobby FDA for drug approval
Although an expert FDA panel voted ten to one to withhold approval for a Biogen anti-Alzheimer's drug candidate, the Alzheimer's Association endorsed the compound. Serious questions have been raised about why, including conflict of interest.
As yet there is no prescription drug to cure mild cognitive impairment (MCI), often a harbinger of Alzheimer's disease. Medical research journals reveal curcumin can sometimes bolster cognition. It merits a try.
After years of paltry funding, research on the possible role of microbes in the causation of Alzheimer's disease will now get a major infusion of grants from the NIH's National Institute on Aging
Although cardiologists often decry coconut oil because of certain fats it contains, they overlook the growing evidence that other fatty constituents, especially medium-chain triglycerides, may alleviate some cases of mild cognitive impairment and Alzheimer's disease
Most medical conflict-of-interest regulations focus on additional money influencing one's opinion. Little consideration is given to the retention of one's job while recommending others lose theirs. Disclosure can counterbalance this. .
Mild cognitive impairment affects millions of seniors. There is no curative drug. Seven possibly helpful supplements gleaned from medical journal articles are described
Biogen tried, and failed, to win FDA committee approval for its anti-amyloid Alzheimer's drug. The Alzheimer's Association supported the application but did not reveal significant monies received from the firm.
MCI911.com had added a new department, Research Radar, to focus exclusively on advancements to aid fighting MCI
Battling the mild cognitive impairment stage of Alzheimer's may disease may "nip it in the bud".
In a 20-page free special report expert Dr. Mary Newport presents 12 reasons to consider diet ketones to counterattack Mild Cognitive Impairment
Patients with mild cognitive impairment can aggressively utilize currently available substances and practices to try and delay their brain degeneration
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right